Instituto Butantan

[ Editor’s Note: This article was updated on 14 December with additional commentary from securities analysts that arrived after publication of the original version on 13 December. ] Integra LifeSci

[ Editor's Note: Due to a technical issue, some of this article did not appear online when it was originally published on 1 November, so we are republishing it in its entirety. ] Johnson & Johnson

Germany’s BI Licenses Tumor-Specific Antibodies From Singapore Lab Boehringer Ingelheim GmbH and Singapore’s Agency for Science, Technology and Research (A*STAR) unveiled a global licensing agreem

Integra Medical expects the acquisition of regenerative tissue product developer ACell to improve its tissue technologies pipeline and accelerate the company’s overall revenue growth. On 16 December,